Connect Biopharma Holdings (CNTB) Revenue (2024 - 2026)

Connect Biopharma Holdings has disclosed Revenue across 3 years of filings, most recently posting $2.8 million for Q2 2026.

• In Q2 2026, Revenue rose 5666.67% year-over-year to $2.8 million; the TTM figure through Jun 2026 stood at $3.0 million (up 50.28% YoY), while the FY2025 annual figure was $64000.0, down 99.75% from the prior year.
• Revenue came in at $2.8 million for Q2 2026 at Connect Biopharma Holdings, up from $169000.0 in the prior quarter.
• In the past five years, Revenue ranged from a high of $2.8 million in Q2 2026 to a low of $16000.0 in Q3 2025.
• Average Revenue over 3 years is $819666.7, with a median of $433500.0 recorded in 2024.
• Year-over-year, Revenue slumped 98.69% in 2025 and soared 5666.67% in 2026.
• Over 3 years, Revenue stood at $698000.0 in 2024, then plunged by 97.71% to $16000.0 in 2025, then soared by 17200.0% to $2.8 million in 2026.
• Per Business Quant data, the three most recent Revenue figures were $2.8 million in Q2 2026, $169000.0 in Q1 2026, and $16000.0 in Q3 2025.